InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,461.43
(
0.63%
)
US TECH 100
18,588.00
(
0.28%
)
Dow Jones
40,230.40
(
0.94%
)
Brent Oil
81.48
(
0.92%
)
Bitcoin
64,852.18
(
-0.79%
)
Post# of 252677
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 89
Posts 17546
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: None

Wednesday, 01/02/2008 12:10:30 PM

Wednesday, January 02, 2008 12:10:30 PM

Post# of 252677
WRT the INGN comedy

Who on earth is "Canacord Adams analyst Joeseph Pantginis" who has been on a bull on the stock through the entire (and ongoing) release of the mystery P3 data?

Hey, it's possible the drug actually works. But the P3 trials failed miserably, and for any analyst not to understand this is either due to gross incompetance or serious conflict-of-inteerst.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up